Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.

9 Both RSV and shingles pose serious health risks for older adults ... Diabetic Foot Screening, HbA1c Tests, and Lipid Profiles, alongside counselling sessions and accessible services via two clinics ...

Respiratory Illness dashboard, hospitalizations due to influenza, COVID-19 and RSV are down — but that doesn’t mean fewer ...

Pediatric RSV off-season outbreaks and positivity rates increased in China during the COVID-19 pandemic, according to study findings.

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland's molecular clamp technology against life-threatening respiratory viruses.

New research is providing a more precise prediction of COVID-19 severity that can be found by looking at autoantibodies in the nasal cavity, leading to more personalized treatment plans.

COVID-19 presents a broad range of symptoms, varying in intensity from mild to severe and even life-threatening.

For adults aged 60 years or older, respiratory syncytial virus (RSV) vaccination is effective for preventing associat ...

A wide variety of COVID-19 symptoms exist, ranging from mild to severe, and while current strains of the virus generally cause milder symptoms, those with co-morbidities are still at an exponentially ...

New research from Emory University reveals that nasal autoantibodies in COVID-19 patients may help predict disease severity, ...